Diagnostic accuracy of cerebrospinal fluid biomarkers measured by chemiluminescent enzyme immunoassay for Alzheimer disease diagnosis

18F-Florbetaben PET/CT to Assess Alzheimer's Disease: A new Analysis Method for Regional Amyloid Quantification

(2019) Pierpaolo Alongi et al.   JOURNAL OF NEUROIMAGING

Vitamin D and the nervous system

(2019) Giulia Bivona et al.   NEUROLOGICAL RESEARCH

Establishing the 99th percentile for high sensitivity cardiac troponin I in healthy blood donors from Southern Italy

(2019) Luisa Agnello et al.   Biochemia Medica

Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid1–42 measurement

(2019) Chiara Zecca et al.   CLINICA CHIMICA ACTA

Diagnostic performance of a fully automated chemiluminescent enzyme immunoassay for Alzheimer's disease diagnosis

(2019) Silvia Paciotti et al.   CLINICA CHIMICA ACTA

Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Aβ42 and T-Tau assays for Alzheimer’s disease diagnosis

(2019) Jean-Louis Bayart et al.   JOURNAL OF NEUROLOGY

Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies

(2019) Yu Yamazaki et al.   Nature Reviews Neurology

Agreement of amyloid PET and CSF biomarkers for Alzheimer's disease on Lumipulse

(2019) Daniel Alcolea et al.   Annals of Clinical and Translational Neurology

Standardized measurement of circulating vitamin D [25(OH)D] and its putative role as a serum biomarker in Alzheimer's disease and Parkinson's disease

(2019) Giulia Bivona et al.   CLINICA CHIMICA ACTA

Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging

(2018) Suzanne E. Schindler et al.   Alzheimers & Dementia

Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis

(2018) Maria Bjerke et al.   JOURNAL OF ALZHEIMERS DISEASE

Biomarkers for Alzheimer's disease: current status and prospects for the future

(2018) K. Blennow et al.   JOURNAL OF INTERNAL MEDICINE

Automation vs. Experience: Measuring Alzheimer’s Beta-Amyloid 1–42 Peptide in the CSF

(2018) Alexander L. Kollhoff et al.   Frontiers in Aging Neuroscience

Vitamin D basis of Alzheimer’s disease: from genetics to biomarkers

(2018) Erdinç Dursun et al.   Hormones-International Journal of Endocrinology and Metabolism

Factors associated with mild cognitive impairment in a population-based cohort

(2017) Silvio Buscemi et al.   European Journal of Internal Medicine

Alzheimer's disease

(2017) C. A. Lane et al.   EUROPEAN JOURNAL OF NEUROLOGY

Cerebrospinal Fluid Aβ42/Aβ40 as a Means to Limiting Tube- and Storage-Dependent Pre-Analytical Variability in Clinical Setting

(2017) Christelle Gervaise-Henry et al.   JOURNAL OF ALZHEIMERS DISEASE

Concordance Between Different Amyloid Immunoassays and Visual Amyloid Positron Emission Tomographic Assessment

(2017) Shorena Janelidze et al.   JAMA Neurology

Short-term Changes in Gal 3 Circulating Levels After Acute Myocardial Infarction

(2016) Giulia Bivona et al.   ARCHIVES OF MEDICAL RESEARCH

Assessing the commutability of reference material formats for the harmonization of amyloid-β measurements

(2016) Maria Bjerke et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Cerebrospinal Fluid Aβ42/40 Corresponds Better than Aβ42 to Amyloid PET in Alzheimer’s Disease

(2016) Piotr Lewczuk et al.   JOURNAL OF ALZHEIMERS DISEASE

CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

(2016) Shorena Janelidze et al.   Annals of Clinical and Translational Neurology

Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study

(2015) Julien Dumurgier et al.   Alzheimers Research & Therapy

Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria

(2014) Bruno Dubois et al.   LANCET NEUROLOGY

Activity of mannose-binding lectin in centenarians

(2012) Rossella Tomaiuolo et al.   AGING CELL

Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update

(2012) Marta del Campo et al.   Biomarkers in Medicine

Reference measurement procedures for Alzheimer’s disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42

(2012) Niklas Mattsson et al.   Biomarkers in Medicine

The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Guy M. McKhann et al.   Alzheimers & Dementia

The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease

(2011) Marilyn S. Albert et al.   Alzheimers & Dementia

Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative

(2011) Hugo Vanderstichele et al.   Alzheimers & Dementia

Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

(2010) Kaj Blennow et al.   Nature Reviews Neurology

C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients

(2009) Nicoletta Vivona et al.   CLINICAL BIOCHEMISTRY